Mary Elizabeth Strek to Anti-Inflammatory Agents
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Anti-Inflammatory Agents.
Connection Strength
0.473
-
Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. J Rheumatol. 2017 Nov; 44(11):1612-1618.
Score: 0.126
-
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther. 2016 Feb; 36:46-52.
Score: 0.112
-
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
Score: 0.100
-
Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013 Sep 15; 188(6):647-56.
Score: 0.096
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.039